Skip to main content
← Back to companies
Portal Biotech logo

Portal Biotech

0 open
London, England, United KingdomFounded 202157+ employees$37.1M raisedSeries APrivate
Last round: series a · $37.1M · Jun 2025(1 rounds total)
Founded by Andy Heron, Giovanni Maglia
Backed by(10 investors)
Earlybird Venture CapitalNATO Innovation Fund8VCPillar VCWS Investment CompanySCVCWe Venture CapitalOutsized VenturesBritish Business BankAmino Collective

Portal is revolutionising biosensing by bringing precise and universal proteomics and metabolomics to the bench-top. Proteins are the functional unit of biology, involved in every pathway and reaction, every synthesis and chemical modification, that make life possible. To understand proteins and metabolites is to understand ourselves: how we work, our health, how our bodies respond to treatments and interventions. Nanopores are nature’s biosensor — molecular devices with an exquisite sensitivity honed over billions of years of evolution. By using our deep expertise in bioengineering and machine-learning to improve on the remarkable properties of biological nanopores, and combining with our unique microelectronics, our products provide category-defining biological insight on a single-molecule basis. Portal, Portal Biotech and Portal Biotechnologies are trading names of Portal Biotechnology Limited.

Open Positions at Portal Biotech (0 Jobs)

No open positions at the moment.

Browse All Jobs

Ready to start your space career at Portal Biotech?

Shipping like we're funded. We're not. No affiliation.

Sequoia logo
Y Combinator logo
Founders Fund logo
a16z logo